Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localised pancreatic cancer.

Lee B, Lipton L, Cohen J, Tie J, Javed AA, Li L, Goldstein D, Burge M, Cooray P, Nagrial A, Tebbutt NC, Thomson B, Nikfarjam M, Harris M, Haydon A, Lawrence B, Wm Tai D, Simons K, Lennon AM, Wolfgang CL, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P.

Ann Oncol. 2019 Jun 28. pii: mdz200. doi: 10.1093/annonc/mdz200. [Epub ahead of print]

PMID:
31250894
2.

Determining the necessity of phenyl ring π-character in warfarin.

Xing H, Houston SD, Chen X, Jin DY, Savage GP, Tie JK, Williams CM.

Bioorg Med Chem Lett. 2019 Aug 1;29(15):1954-1956. doi: 10.1016/j.bmcl.2019.05.039. Epub 2019 May 23.

PMID:
31147103
3.

Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience.

Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, Tie J, Akhurst T, Mitchell C, Ramsay R, Heriot A.

J Gastrointest Surg. 2019 May 14. doi: 10.1007/s11605-019-04239-4. [Epub ahead of print]

PMID:
31090036
4.

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer.

Wang Y, Li L, Cohen JD, Kinde I, Ptak J, Popoli M, Schaefer J, Silliman N, Dobbyn L, Tie J, Gibbs P, Tomasetti C, Kinzler KW, Papadopoulos N, Vogelstein B, Olsson L.

JAMA Oncol. 2019 May 9. doi: 10.1001/jamaoncol.2019.0512. [Epub ahead of print]

PMID:
31070668
5.

Dynamic Profile of CD4+ T-Cell-Associated Cytokines/Chemokines following Murine Myocardial Infarction/Reperfusion.

Yuan D, Tie J, Xu Z, Liu G, Ge X, Wang Z, Zhang X, Gong S, Liu G, Meng Q, Lin F, Liu Z, Fan H, Zhou X.

Mediators Inflamm. 2019 Mar 18;2019:9483647. doi: 10.1155/2019/9483647. eCollection 2019.

6.

Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia.

Delahunty R, Lee M, Wong H, Johns J, McKendrick J, Lee B, Kosmider S, Cooray P, Ananda S, Desai J, Tran B, Tie J, Gibbs P, Wong R.

Intern Med J. 2019 Mar 18. doi: 10.1111/imj.14288. [Epub ahead of print]

PMID:
30887616
7.

Quality evaluation of flue-cured tobacco by near infrared spectroscopy and spectral similarity method.

Bi Y, Li S, Zhang L, Li Y, He W, Tie J, Liao F, Hao X, Tian Y, Tang L, Wu J, Wang H, Xu Q.

Spectrochim Acta A Mol Biomol Spectrosc. 2019 May 15;215:398-404. doi: 10.1016/j.saa.2019.01.094. Epub 2019 Mar 6.

PMID:
30865909
8.

Registry-based randomized clinical trials as a method to improve cancer care in Australia.

Foroughi S, Wong HL, Gately L, Lee M, Simons K, Tie J, Burgess AW, Gibbs P.

Asia Pac J Clin Oncol. 2019 Jun;15(3):188-189. doi: 10.1111/ajco.13122. Epub 2019 Feb 12. No abstract available.

PMID:
30747499
9.

Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms.

Narasimhan V, Pham T, Warrier S, Craig Lynch A, Michael M, Tie J, Ramsay R, Heriot A.

ANZ J Surg. 2019 Jan 26. doi: 10.1111/ans.14985. [Epub ahead of print]

PMID:
30685879
10.

Cyclooctatetraene: A Bioactive Cubane Paradigm Complement.

Xing H, Houston SD, Chen X, Ghassabian S, Fahrenhorst-Jones T, Kuo A, Murray CP, Conn KA, Jaeschke KN, Jin DY, Pasay C, Bernhardt PV, Burns JM, Tsanaktsidis J, Savage GP, Boyle GM, De Voss JJ, McCarthy J, Walter GH, Burne THJ, Smith MT, Tie JK, Williams CM.

Chemistry. 2019 Feb 21;25(11):2729-2734. doi: 10.1002/chem.201806277. Epub 2019 Jan 25.

PMID:
30681236
11.

The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations.

Wong R, Tie J, Lee M, Cohen J, Wang Y, Li L, Ma S, Christie M, Kosmider S, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P.

Int J Cancer. 2019 Jul 15;145(2):540-547. doi: 10.1002/ijc.32117. Epub 2019 Jan 24.

PMID:
30628066
12.

Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?

Semira C, Wong HL, Field K, Lee M, Lee B, Nott L, Shapiro J, Wong R, Tie J, Tran B, Richardson G, Zimet A, Lipton L, Tamjid B, Burge M, Ma B, Johns J, Harold M, Gibbs P.

Intern Med J. 2019 Apr;49(4):446-454. doi: 10.1111/imj.14115.

PMID:
30230679
13.

Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.

Chen X, Jin DY, Stafford DW, Tie JK.

Blood. 2018 Nov 1;132(18):1974-1984. doi: 10.1182/blood-2018-05-846592. Epub 2018 Aug 8.

PMID:
30089628
14.

MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.

Yang L, Men WL, Yan KM, Tie J, Nie YZ, Xiao HJ.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4837-4845. doi: 10.26355/eurrev_201808_15619.

15.

Impacts of Fe2+ on 5-aminolevulinic acid (ALA) biosynthesis of Rhodobacter sphaeroides in wastewater treatment by regulating nif gene expression.

Liu S, Zheng Z, Tie J, Kang J, Zhang G, Zhang J.

J Environ Sci (China). 2018 Aug;70:11-19. doi: 10.1016/j.jes.2017.11.001. Epub 2017 Nov 11.

PMID:
30037398
16.

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern.

Prasanna T, Karapetis CS, Roder D, Tie J, Padbury R, Price T, Wong R, Shapiro J, Nott L, Lee M, Chua YJ, Craft P, Piantadosi C, Sorich M, Gibbs P, Yip D.

Acta Oncol. 2018 Nov;57(11):1438-1444. doi: 10.1080/0284186X.2018.1487581. Epub 2018 Jul 23.

PMID:
30035653
17.

Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.

Wang E, Xia D, Bai W, Wang Z, Wang Q, Liu L, Wang W, Yuan J, Li X, Chen H, Lv Y, Niu J, He C, Guo W, Yin Z, Luo B, Han N, Wang Z, Yu T, Yuan X, Li K, Tie J, Li C, Cai H, Xia J, Fan D, Han G.

Invest New Drugs. 2019 Jun;37(3):401-414. doi: 10.1007/s10637-018-0640-7. Epub 2018 Jul 18.

PMID:
30019101
18.

Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.

Wong HL, Christie M, Gately L, Tie J, Lee B, Semira C, Lok SW, Wong R, Gibbs P.

Future Oncol. 2018 Nov;14(26):2725-2739. doi: 10.2217/fon-2018-0319. Epub 2018 Jul 13. Review.

PMID:
30004261
19.

[Diagnostic value of transient elastography for diagnosis of idiopathic non-cirrhotic portal hypertension].

He CY, Lyu Y, Chen H, Liu HB, Wang QH, Fan JH, Luo BH, Yu TL, Yuan XL, Tie J, Niu J, Guo WG, Yin ZX, Han GH.

Zhonghua Gan Zang Bing Za Zhi. 2018 Apr 20;26(4):310-312. doi: 10.3760/cma.j.issn.1007-3418.2018.04.015. Chinese. No abstract available.

PMID:
29996345
20.

Genotyping DNA isolated from UV irradiated human bloodstains using whole genome amplification.

Uchigasaki S, Tie J, Sobashima E, Shimada N.

Mol Biol Rep. 2018 Oct;45(5):925-929. doi: 10.1007/s11033-018-4240-6. Epub 2018 Jul 7.

PMID:
29982892
21.

Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.

Lee MM, MacKinlay A, Semira C, Schieber C, Jimeno Yepes AJ, Lee B, Wong R, Hettiarachchige CKH, Gunn N, Tie J, Wong HL, Skinner I, Jones IT, Keck J, Kosmider S, Tran B, Field K, Gibbs P.

Clin Colorectal Cancer. 2018 Sep;17(3):e569-e577. doi: 10.1016/j.clcc.2018.05.008. Epub 2018 May 26.

PMID:
29980491
22.

Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.

He C, Lv Y, Wang Z, Guo W, Tie J, Li K, Niu J, Zuo L, Yu T, Yuan X, Chen H, Wang Q, Liu H, Bai W, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Wang J, Yin Z, Fan D, Han G.

Dig Liver Dis. 2018 Dec;50(12):1315-1323. doi: 10.1016/j.dld.2018.05.022. Epub 2018 Jun 5.

PMID:
29960900
23.

Re-inventing the randomized controlled trial in medical oncology: The registry-based trial.

Foroughi S, Wong HL, Gately L, Lee M, Simons K, Tie J, Burgess AW, Gibbs P.

Asia Pac J Clin Oncol. 2018 Dec;14(6):365-373. doi: 10.1111/ajco.12992. Epub 2018 Jun 26. Review.

PMID:
29947051
24.

Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.

Wu S, Chen X, Jin DY, Stafford DW, Pedersen LG, Tie JK.

Blood. 2018 Aug 9;132(6):647-657. doi: 10.1182/blood-2018-01-830901. Epub 2018 May 9.

PMID:
29743176
25.

Compensation of Horizontal Gravity Disturbances for High Precision Inertial Navigation.

Tie J, Cao J, Wu M, Lian J, Cai S, Wang L.

Sensors (Basel). 2018 Mar 18;18(3). pii: E906. doi: 10.3390/s18030906.

26.

A Model of Gravity Vector Measurement Noise for Estimating Accelerometer Bias in Gravity Disturbance Compensation.

Tie J, Cao J, Chang L, Cai S, Wu M, Lian J.

Sensors (Basel). 2018 Mar 16;18(3). pii: E883. doi: 10.3390/s18030883.

27.

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.

Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P.

Gut. 2019 Apr;68(4):663-671. doi: 10.1136/gutjnl-2017-315852. Epub 2018 Feb 2.

PMID:
29420226
28.

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S, Bettegowda C, Diaz LA Jr, Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N.

Science. 2018 Feb 23;359(6378):926-930. doi: 10.1126/science.aar3247. Epub 2018 Jan 18.

29.

Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers.

Lee B, Hutchinson R, Wong HL, Tie J, Putoczki T, Tran B, Gibbs P, Christie M.

Semin Cancer Biol. 2018 Oct;52(Pt 2):241-252. doi: 10.1016/j.semcancer.2017.12.009. Epub 2017 Dec 16. Review.

PMID:
29258858
30.

Vitamin K epoxide reductase and its paralogous enzyme have different structures and functions.

Sinhadri BCS, Jin DY, Stafford DW, Tie JK.

Sci Rep. 2017 Dec 15;7(1):17632. doi: 10.1038/s41598-017-18008-3.

31.

Outcome of Hook Plate Fixation of Mallet Fractures.

Tie J, Hsieh MKH, Tay SC.

J Hand Surg Asian Pac Vol. 2017 Dec;22(4):416-422. doi: 10.1142/S0218810417500435.

PMID:
29117843
32.

Clinical guidance for radioiodine refractory differentiated thyroid cancer.

Gild ML, Topliss DJ, Learoyd D, Parnis F, Tie J, Hughes B, Walsh JP, McLeod DSA, Clifton-Bligh RJ, Robinson BG.

Clin Endocrinol (Oxf). 2018 Apr;88(4):529-537. doi: 10.1111/cen.13508. Epub 2017 Nov 24. Review.

PMID:
29095527
33.

Precision oncology using a clinician-directed, tailored approach to molecular profiling.

Lam M, Tran B, Beck S, Tie J, Herath D, Whittle J, Kwan EM, Fox SB, Fellowes A, Ananda S, Lipton L, Gibbs P, Rosenthal MA, Desai J.

Asia Pac J Clin Oncol. 2018 Feb;14(1):84-90. doi: 10.1111/ajco.12787. Epub 2017 Oct 30.

PMID:
29083093
34.

Surface micropattern reduces colonization and medical device-associated infections.

Xu B, Wei Q, Mettetal MR, Han J, Rau L, Tie J, May RM, Pathe ET, Reddy ST, Sullivan L, Parker AE, Maul DH, Brennan AB, Mann EE.

J Med Microbiol. 2017 Nov;66(11):1692-1698. doi: 10.1099/jmm.0.000600. Epub 2017 Oct 6.

35.

Study of the association between hemorrhage and the position of hemorrhagic stigmata in patients with esophageal varices.

Shen SH, Liu YD, Sun X, Li M, Sun GH, Wang J, Liu JT, Tie J, Yang J.

Exp Ther Med. 2017 Sep;14(3):2261-2264. doi: 10.3892/etm.2017.4727. Epub 2017 Jul 9.

36.

Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?

Tie J, Semira C, Gibbs P.

Expert Rev Mol Diagn. 2018 Jan;18(1):1-3. doi: 10.1080/14737159.2018.1386558. Epub 2017 Oct 6. No abstract available.

PMID:
28954554
37.

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.

Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider MT, Allen PJ, Schattner M, Brand RE, Singhi AD, Petersen GM, Hong SM, Kim SC, Falconi M, Doglioni C, Weiss MJ, Ahuja N, He J, Makary MA, Maitra A, Hanash SM, Dal Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Goggins MG, Hruban RH, Wolfgang CL, Klein AP, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Lennon AM.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10202-10207. doi: 10.1073/pnas.1704961114. Epub 2017 Sep 5.

38.

IL-17 contributes to the pathogenesis of obliterative bronchiolitis via regulation of M1 macrophages polarization in murine heterotopic trachea transplantation models.

Meng Q, Liu J, Lin F, Bao L, Jiang Y, Zheng L, Tie J, Zhang L, Liang X, Wei L, Li Y, Fan H, Zhou X.

Int Immunopharmacol. 2017 Nov;52:51-60. doi: 10.1016/j.intimp.2017.08.022. Epub 2017 Aug 31.

PMID:
28863322
39.

Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.

Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, Zhang L, Wang Q, Liu H, Luo B, Niu J, Li K, Tie J, Yin Z, Fan D, Han G.

Radiology. 2017 Dec;285(3):999-1010. doi: 10.1148/radiol.2017162266. Epub 2017 Jul 5.

PMID:
28682164
40.

Molecular basis of the first reported clinical case of congenital combined deficiency of coagulation factors.

Jin DY, Ingram BO, Stafford DW, Tie JK.

Blood. 2017 Aug 17;130(7):948-951. doi: 10.1182/blood-2017-05-782367. Epub 2017 Jul 5. No abstract available.

41.

A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.

Michael M, Bang YJ, Park YS, Kang YK, Kim TM, Hamid O, Thornton D, Tate SC, Raddad E, Tie J.

Target Oncol. 2017 Aug;12(4):463-474. doi: 10.1007/s11523-017-0502-9.

PMID:
28589492
42.

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies.

Rohr UP, Herrmann P, Ilm K, Zhang H, Lohmann S, Reiser A, Muranyi A, Smith J, Burock S, Osterland M, Leith K, Singh S, Brunhoeber P, Bowermaster R, Tie J, Christie M, Wong HL, Waring P, Shanmugam K, Gibbs P, Stein U.

Ann Oncol. 2017 Aug 1;28(8):1869-1875. doi: 10.1093/annonc/mdx207.

PMID:
28460000
43.

miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.

Zhang X, Dong J, He Y, Zhao M, Liu Z, Wang N, Jiang M, Zhang Z, Liu G, Liu H, Nie Y, Fan D, Tie J.

Gene. 2017 Jun 5;615:42-49. doi: 10.1016/j.gene.2017.03.022. Epub 2017 Mar 18.

PMID:
28323002
44.

How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?

Au L, Turner N, Wong HL, Field K, Lee B, Boadle D, Cooray P, Karikios D, Kosmider S, Lipton L, Nott L, Parente P, Tie J, Tran B, Wong R, Yip D, Shapiro J, Gibbs P.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e167-e174. doi: 10.1111/ajco.12671. Epub 2017 Mar 16.

PMID:
28299879
45.

Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Tie JK, Stafford DW.

Methods Enzymol. 2017;584:349-394. doi: 10.1016/bs.mie.2016.10.015. Epub 2016 Nov 22.

46.

The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study.

Lee B, Wong HL, Tacey M, Tie J, Wong R, Lee M, Nott L, Shapiro J, Jennens R, Turner N, Tran B, Ananda S, Yip D, Richardson G, Parente P, Lim L, Stefanou G, Burge M, Iddawela M, Power J, Gibbs P.

Asia Pac J Clin Oncol. 2017 Aug;13(4):314-321. doi: 10.1111/ajco.12639. Epub 2016 Nov 25.

PMID:
27885818
47.

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.

Murphy C, Turner N, Wong HL, Sinnathamby M, Tie J, Lee B, Desai J, Skinner I, Christie M, Hutchinson R, Lunke S, Waring P, Gibbs P, Tran B.

Intern Med J. 2017 Jan;47(1):88-98. doi: 10.1111/imj.13312.

PMID:
27800646
48.

Splice-Site Mutation of Exon 3 Deletion in the Gamma-Glutamyl Carboxylase Gene Causes Inactivation of the Enzyme.

Jin DY, Vermeer C, Stafford DW, Tie JK.

J Invest Dermatol. 2016 Nov;136(11):2314-2317. doi: 10.1016/j.jid.2016.05.128. Epub 2016 Jul 6. No abstract available.

49.

Epigenetic roles in the malignant transformation of gastric mucosal cells.

Tie J, Zhang X, Fan D.

Cell Mol Life Sci. 2016 Dec;73(24):4599-4610. Epub 2016 Jul 27. Review.

50.

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.

Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, Kosmider S, Skinner I, Wong R, Steel M, Tran B, Desai J, Jones I, Haydon A, Hayes T, Price TJ, Strausberg RL, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P.

Sci Transl Med. 2016 Jul 6;8(346):346ra92. doi: 10.1126/scitranslmed.aaf6219.

Supplemental Content

Support Center